Your gateway to UAB innovations

The UAB Bill L. Harbert Institute for Innovation and Entrepreneurship (HIIE) acts as the point of contact for industry and entrepreneurs wishing to access the university's intellectual and tangible property, and actively seeks contact with national and international companies that wish to develop and commercialize UAB's innovations.

The HIIE manages a broad range of technologies developed at UAB. Innovations available for licensing span a variety of medical therapeutic areas, including technologies for diagnosis and treatment of cancer, autoimmune diseases, cardiovascular diseases, and central nervous system disorders. They include platform technologies, research tools, diagnostics, and therapeutics such as gene therapy and vaccines, and vary in developmental status from really early to late stage technologies, including clinical trials. UAB also has a strong portfolio of engineering, biomaterials and computer technologies with a wide variety of industrial and medical applications.

Click here to search a sample of the technologies available for licensing. The listings presented on the webpage are not comprehensive and cannot substitute for detailed communication regarding specific problems you are trying to resolve. You may want to call to speak to one of our licensing professionals at (205) 934-9911. They will be able to suggest recent innovations of interest and assist you with your needs.

If you do not see what you're looking for, please feel free to This email address is being protected from spambots. You need JavaScript enabled to view it. us to describe your specific technology needs. A licensing associate will contact you.

Available Technologies

Research Tools

Frequently Asked Questions

What technologies are available for license from the HIIE?

A broad range of technologies are available for license. We have an especially strong portfolio in medical, biomaterial, and pharmaceutical technologies; computer, engineering, and other technologies are also available. We encourage you to talk with a licensing associate about your company’s interests or This email address is being protected from spambots. You need JavaScript enabled to view it. about what you’re looking for. A licensing associate may also make the initial contact with you if we see a match between certain UABRF technologies and your company’s field.

Do I need to sign a confidential disclosure agreement (CDA) before I get any information?

No, in most cases a HIIE licensing associate can share some general information about a technology’s possible uses and benefits without the need for a CDA. If you are interested in learning more, then the licensing associate can get a CDA in place with you in order to share proprietary information or confidential details about the innovation. At that point we may set up a meeting or conference call including the primary investigator who developed the technology.

Do you license to startup companies?

YES. We are proud of the many successful companies that have been started based on UAB technologies. However, our primary responsibility as steward of these technologies is to the university, so we must consider whether licensing a technology to a start-up company is more likely to create public good and university revenue than licensing it to an established company. Thus, we would likely ask for information on your management team, funding, and business plan in evaluating whether this license opportunity is a good fit for the university. We will consider compensation in the form of equity rather than cash, but again must weigh this compensation versus other licensing opportunities that may be available.

Do you advise or fund companies?

No. However, there are other organizations in the area that do. For example, Innovation Depot is UAB’s high-tech business incubator and can provide support services for new businesses, and the Birmingham Venture Club is an organization of those that own, fund and provide services to businesses.

Who do I contact for specific questions about a technology?